Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.
purpleDx is a smartphone app with accompanying clinical dashboard to support clinicians in detecting, monitoring, and treating pulmonary diseases, including asthma, chronic obstructive pulmonary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback